Success Metrics

Clinical Success Rate
80.5%

Based on 603 completed trials

Completion Rate
81%(603/749)
Active Trials
675(41%)
Results Posted
47%(281 trials)
Terminated
146(9%)

Phase Distribution

Ph phase_1
135
8%
Ph early_phase_1
37
2%
Ph phase_3
147
9%
Ph phase_4
18
1%
Ph phase_2
391
24%
Ph not_applicable
641
39%

Phase Distribution

172

Early Stage

391

Mid Stage

165

Late Stage

Phase Distribution1369 total trials
Early Phase 1First-in-human
37(2.7%)
Phase 1Safety & dosage
135(9.9%)
Phase 2Efficacy & side effects
391(28.6%)
Phase 3Large-scale testing
147(10.7%)
Phase 4Post-market surveillance
18(1.3%)
N/ANon-phased studies
641(46.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

603 of 845 finished

Non-Completion Rate

28.6%

242 ended early

Currently Active

675

trials recruiting

Total Trials

1,655

all time

Status Distribution
Active(719)
Completed(603)
Terminated(242)
Other(91)

Detailed Status

Completed603
Recruiting355
Active, not recruiting320
Terminated146
Withdrawn96
unknown69

Development Timeline

Analytics

Development Status

Total Trials
1655
Active
675
Success Rate
80.5%
Most Advanced
Phase 4

Trials by Phase

Early Phase 137 (2.7%)
Phase 1135 (9.9%)
Phase 2391 (28.6%)
Phase 3147 (10.7%)
Phase 418 (1.3%)
N/A641 (46.8%)

Trials by Status

suspended221%
completed60336%
terminated1469%
unknown694%
enrolling_by_invitation20%
active_not_recruiting32019%
not_yet_recruiting423%
recruiting35521%
withdrawn966%

Recent Activity

Clinical Trials (1,655)

Showing 20 of 1,655 trialsScroll for more
NCT07094750Not Applicable

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Recruiting
NCT04560712Not Applicable

Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery

Active Not Recruiting
NCT05132296Not Applicable

Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer

Active Not Recruiting
NCT06064097Phase 2

A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)

Recruiting
NCT04269902Phase 3

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Recruiting
NCT04729322Phase 2

Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders

Active Not Recruiting
NCT03244384Phase 3

Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

Active Not Recruiting
NCT00991094

Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy

Recruiting
NCT05178498

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Recruiting
NCT04267848Phase 3

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Recruiting
NCT06763328Phase 3

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

Recruiting
NCT05092958Phase 3

Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study

Active Not Recruiting
NCT05630794Phase 1

Testing for Safety and Colorectal Cancer Preventive Effects of ONC201

Recruiting
NCT05675410Phase 3

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Recruiting
NCT05557877Phase 2

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Recruiting
NCT04567771Not Applicable

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Active Not Recruiting
NCT06995898Not Applicable

The Vanguard Study: Testing a New Way to Screen for Cancer

Recruiting
NCT02079662Not Applicable

The Role of Lifestyle Factors in Breast Cancer-Related Outcomes

Active Not Recruiting
NCT05987241Phase 2

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

Recruiting
NCT02697227Not Applicable

Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation

Active Not Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
1,655